Maxcyte (MXCT) Non-Current Assets (2020 - 2026)

Maxcyte (MXCT) has reported Non-Current Assets for 7 consecutive years, with $63.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 17.16% year-over-year to $63.4 million in Q2 2026; TTM through Jun 2026 was $307.9 million, a 4.65% increase from a year earlier, with the FY2025 full-year figure at $84.1 million, up 24.12% from the prior year.
• Non-Current Assets was $63.4 million for Q2 2026 at Maxcyte, down from $71.5 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $88.8 million in Q3 2025 and troughed at $25.2 million in Q1 2022.
• A 5-year average of $60.2 million and a median of $69.7 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 318.61% in 2022 and retreated 17.16% in 2026, its largest moves.
• Over 5 years, Non-Current Assets stood at $34.4 million in 2022, then jumped by 127.06% to $78.1 million in 2023, then fell by 13.18% to $67.8 million in 2024, then climbed by 24.12% to $84.1 million in 2025, then decreased by 24.65% to $63.4 million in 2026.
• The last three Non-Current Assets figures came in at $63.4 million (Q2 2026), $71.5 million (Q1 2026), and $84.1 million (Q4 2025), per Business Quant data.